Malignant melanoma is one of the most common cancers in the world. In the disease's early
stages, treatment involves surgery, in advanced stages however, treatment options were …

Simple Summary The prognosis and treatment of metastatic melanoma have changed
substantially since the advent of target therapy and immune checkpoint inhibitors. Thus …

This review aims to summarize the current knowledge of molecular pathways and their
clinical relevance in melanoma. Metastatic melanoma was a grim diagnosis, but in recent …

Despite enormous international efforts, skin melanoma is still a major clinical challenge.
Melanoma takes a top place among the most common cancer types and it has one of the …

Progress in understanding the molecular basis of melanoma has made possible the
identification of molecular targets with important implications in clinical practice. In fact, new …

Melanoma, a highly aggressive skin cancer, is characterized by rapid progression and high
mortality. Recent advances in molecular pathogenesis have shed light on genetic and …

Skin cancer is divided to melanoma and non-melanoma. Melanoma occurs due to
deregulation of melanocytes. Melanoma is frequent in Caucasian population. During the last …

Melanoma is the most deadly skin cancer. The incidence and mortality rates of this tumor
have been increasing over the last number of decades. Besides clinical and …

In an era of personalized medicine, disease specific biomarkers play an increasing role in
the stratification of high-risk patient groups. Cutaneous malignant melanoma is the most …

The treatment landscape for advanced melanoma has been rapidly evolving. As new
therapies become available, there is a need for better biomarkers to detect disease, guide …